Lv1
34 积分 2024-09-24 加入
Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
4小时前
已完结
Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine
1个月前
已完结
维布妥昔单抗单药或联合苯达莫司汀治疗NK/T淋巴瘤的作用
1个月前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
3个月前
已完结
Expert consensus on the treatment of dermatoses with targeted drugs (2025 version)
3个月前
已完结
Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis
3个月前
已完结
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
4个月前
已关闭
Adding brentuximab vedotin to lenalidomide and rituximab improves OS in R/R DLBCL
4个月前
已完结
Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma
4个月前
已关闭
皖公网安备34019202002308
